Codexis Newsroom

Codexis to Participate in Jefferies Global Healthcare Conference

REDWOOD CITY, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading enzyme engineering company, today announced the Company will attend the Jefferies Global Healthcare Conference, being held

GlobeNewswireMay 22 16:25 ET

Codexis to Participate in TD Cowen 2nd Annual Sustainability Week

REDWOOD CITY, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading enzyme engineering company, today announced the Company will participate in a panel discussion titled, "Sustainable API

GlobeNewswireMay 20 16:05 ET

Stifel Nicolaus Reaffirms Their Buy Rating on Codexis (CDXS)

TipRanksMay 20 07:55 ET

Express News | Codexis Inc -May Offer & Sell Shares of Common Stock Having an Aggregate Offering Price of up to $75 Mln From Time to Time Through or to Cantor

ReutersMay 14 09:15 ET

Express News | Codexis Inc - Entered Into Controlled Equity Offering Sales Agreement Relating to Sale of Shares of Common Stock

ReutersMay 14 09:14 ET

Codexis (CDXS) Gets a Buy From Craig-Hallum

TipRanksMay 14 09:05 ET

Express News | Codexis Successfully Synthesizes An Oligonucleotide Via An Enzymatic Route To Support RNA-Based Therapeutics Manufacturing

BenzingaMay 14 06:12 ET

Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting

REDWOOD CITY, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading enzyme engineering company, today announced it has successfully synthesized an oligonucleotide via an enzymatic route to

GlobeNewswireMay 14 06:00 ET

Is Codexis (NASDAQ:CDXS) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it seems the smart money knows that debt - which is usu

Simply Wall StMay 5 09:38 ET

Codexis First Quarter 2024 Earnings: Beats Expectations

Yahoo FinanceMay 4 09:45 ET

Express News | Benchmark Reiterates Buy on Codexis, Maintains $9 Price Target

BenzingaMay 3 13:31 ET

Codexis Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 127.27% Benchmark → $9 Reiterates Buy → Buy 02/29/2024 127.27% Benchmark → $9 Upgrades Hold → B

BenzingaMay 3 13:29 ET

Express News | Codexis Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results

BenzingaMay 3 11:59 ET

Earnings Call Summary | Codexis(CDXS.US) Q1 2024 Earnings Conference

The following is a summary of the Codexis, Inc. (CDXS) Q1 2024 Earnings Call Transcript:Financial Performance:Codexis reported Q1 2024 total revenues of $17.1 million, an increase of 32% year-over-yea

moomoo AIMay 3 09:41 ET · Conference Call

Benchmark Co. Sticks to Their Buy Rating for Codexis (CDXS)

TipRanksMay 3 07:38 ET

Q1 2024 Codexis Inc Earnings Call

Yahoo FinanceMay 3 06:47 ET

Express News | Codexis Shares up 10.2% Premarket After Q1 Results

ReutersMay 3 04:25 ET

Codexis Inc (CDXS) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...

Yahoo FinanceMay 3 04:01 ET

Codexis, Inc. (CDXS) Q1 2024 Earnings Call Transcript

Codexis, Inc. (CDXS) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 2 20:24 ET

Codexis Inc (CDXS) Q1 2024 Earnings: Surpasses Revenue Forecasts With Strategic Advances

Yahoo FinanceMay 2 18:06 ET